Status:

COMPLETED

Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer

Lead Sponsor:

Organ, Tissue, Regeneration, Repair and Replacement

Conditions:

Oral Mucositis

Carcinoma in Situ of Upper Respiratory Tract

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

MUCIPLIQ is a nanopolymer engineered to mimic glycosaminoglycans such as heparan sulfates. Glycosaminoglycans are involved 1) in the stabilization of cells micro-environment, known as extracellular ma...

Eligibility Criteria

Inclusion

  • Patient suffering from an upper aerodigestive tract carcinoma treated by radiotherapy alone or radiotherapy associated with a concomitant platine-salts-based chemotherapy ;
  • Patient suffering of an upper aerodigestive tract carcinoma without entrance or located in the oral cavity, in the oropharynx or in the rhinopharynx ;
  • Patient age of 18 years old or higher ;
  • Writing informed consent to participate to the trial ;
  • Patient affiliated to the French social security system.

Exclusion

  • Treatment by non-standard fragmentation (concentrate irradiation)
  • Carcinoma located in the hypopharynx or in the larynx ;
  • Known hypersensitivity to heparinoids ;
  • Patient who already benefited from a radiotherapy treatment ;
  • Patient who already benefited from a chemotherapy treatment. Patients who benefited from neoadjuvant chemotherapy as part of their upper aerodigestive tract carcinoma care, may be included if it was held at least 4 weeks before the inclusion visit ;
  • Patient participating to another biomedical research ;
  • Pregnant woman, breastfeeding woman, parturient or likely to be ;
  • Patient deprived of freedom, under supervision or guardianship ;
  • Patient unable to attend to scheduled medical monitoring due to geographical, social or mental reasons

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2015

Estimated Enrollment :

136 Patients enrolled

Trial Details

Trial ID

NCT01840436

Start Date

March 1 2013

End Date

January 1 2015

Last Update

May 5 2016

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Centre de Cancérologie Léon Bérard

Lyon, France, 69373

2

CHRU de Besançon, Site du CH Belfort-Montbéliard

Montbéliard, France, 25200

3

Centre Hospitalier Intercommunal de Créteil

Créteil, Île-de-France Region, France, 94010

4

APHP - Hôpital Tenon

Paris, Île-de-France Region, France, 75970